Worthington, OH, United States of America

Thomas Joel Zupancic

This inventor holds 17 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Hematopoietic Development. Top assignees: Progenitor, Inc., Indevus Pharmaceuticals, Inc., Vanderbilt University. Active years: 1997-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Joel Zupancic. Retrieved from https://idiyas.com/inventor/thomas-joel-zupancic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 88.2

 

 

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 1997-2006

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Hematopoietin Receptor
Leptin Receptor
Polypeptides
Obesity
Developmentally-Regulated
Antibodies
Nucleic Acid
Screening Methods
Ligands
Biological Activity
Gene Products
Promoter DNA
17 patents (USPTO):Explore Patents

Title: The Innovations of Thomas Joel Zupancic

Introduction

Thomas Joel Zupancic is a prolific inventor hailing from Worthington, OH, with an impressive portfolio that includes 17 patents. His work primarily focuses on advancements in biotechnology and molecular biology, particularly involving endothelial cells and obesity-related genetics.

Latest Patents

Among his most recent contributions to science are patents addressing critical health issues. One notable invention is centered around antibodies that bind to polypeptides encoded by a novel gene family known as developmentally-regulated endothelial cell locus-1 (del-1). This innovation includes nucleotide and amino acid sequences related to del-1, opening new avenues for cancer and endothelial cell research. The potential applications of these anti-Del-1 antibodies include immunological assessment and modulation of Del-1 function, potentially serving as markers for both endothelial cells and tumors.

Another significant patent focuses on identifying compounds capable of enhancing the biological activity of leptin, a hormone crucial for regulating body weight. Zupancic's work on a receptor variant linked to the obese gene offers methods to detect its presence in obese individuals and ways to improve leptin’s effectiveness. These methods have significant implications for weight management and obesity treatment, showcasing his commitment to tackling challenging health issues.

Career Highlights

Zupancic's career features key roles in prominent organizations, including Progenitor, Inc., a company specializing in biotechnology innovations, and Vanderbilt University, a renowned research institution focused on advancing health sciences. His tenure at these institutions has allowed him to develop and refine his pioneering inventions, contributing to the scientific community’s understanding of critical health-related phenomena.

Collaborations

Throughout his career, Zupancic has collaborated with noted professionals like H Ralph Snodgrass and Joseph Cioffi. These partnerships have fostered an environment for innovation and research, leading to the successful development of patented technologies that address significant biological questions.

Conclusion

Thomas Joel Zupancic stands out as a significant figure in the realm of biotechnology, having made substantial contributions through his 17 patents. His innovative solutions to pressing health concerns reflect not only his expertise but also his dedication to advancing scientific knowledge. Zupancic's work serves as an inspiration for future inventors in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…